INTEGRATED FILING — Other than Banks



General information about company

Scrip code 000000
NSE Symbol IPHL
MSEI Symbol NOTLISTED
ISIN INE0DHF01018
Name of Company Indian Phosphate Limited
Type of company SME
Class of security Equity
Date of start of financial year 01-04-2025
Date of end of financial year 31-03-2026
Date of board meeting when results were approved 14-11-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 05-11-2025
Description of presentation currency INR
Level of rounding used in financial results Lakhs
Reporting Type Half Yearly
Reporting Quarter Half yearly
Nature of report standalone or consolidated Consolidated
Whether results are audited or unaudited for the quarter ended Unaudited
Whether results are audited or unaudited for the Year to date for current period ended/year ended
Segment Reporting Multi segment
Description of single segment
Start date and time of board meeting 14-11-2025   15:00:00
End date and time of board meeting 14-11-2025   17:30:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Not applicable


Financial Results — Other than Bank

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-04-2025 01-04-2025
B Date of end of reporting period 30-09-2025 30-09-2025
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Consolidated Consolidated
1 Revenue From Operations
Revenue from operations 49,913.44 49,913.44
Other income 50.59 50.59
Total Income 49,964.03 49,964.03
2 Expenses
(a) Cost of materials consumed 41,768.61 41,768.61
(b) Purchases of stock-in-trade 161.60 161.60
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade 637.99 637.99
(d) Employee benefit expense 667.64 667.64
(e) Finance costs 346.62 346.62
(f) Depreciation and amortisation expense 197.88 197.88
(g) Other Expenses
1 MANUFACTURING EXPENSES 781.72 781.72
2 SELLING AND DISTRIBUTION EXPENSES 3,478.86 3,478.86
3 ADMINISTRATIVE AND OTHER EXPENSES 501.80 501.80
Total other expenses 4,762.38 4,762.38
Total expenses 48,542.72 48,542.72
3 Profit before exceptional and extraordinary items and tax 1,421.31 1,421.31
4 Exceptional items 0.00 0.00
5 Profit before extraordinary items and tax 1,421.31 1,421.31
6 Extraordinary items 0.00 0.00
7 Profit before tax 1,421.31 1,421.31
8 Tax Expense
Current tax 249.59 249.59
Deferred tax 155.19 155.19
Total tax expenses 404.78 404.78
9 Net Profit Loss for the period from continuing operations 1,016.53 1,016.53
10 Profit (loss) from discontinuing operations before tax 0.00 0.00
11 Tax expense of discontinuing operations 0.00 0.00
12 Net profit (loss) from discontinuing operation after tax 0.00 0.00
13 Profit (loss) for period before minority interest 1,016.53 1,016.53
14 Share of profit (loss) of associates 0.00 0.00
15 Profit (loss) of minority interest (186.52) (186.52)
16 Net profit (Loss) for the period 830.01 830.01
17 Details of equity share capital
Paid-up equity share capital 2,498.96 2,498.96
Face value of equity share capital 10 10
18 Reserves excluding revaluation reserve
19 Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 3.32 3.32
Diluted earnings (loss) per share from continuing and discontinued operations 3.32 3.32
20 Debt equity ratio
21 Debt service coverage ratio
22 Interest service coverage ratio
23 Disclosure of notes on financial results


Remarks

20 Debt equity ratio
21 Debt service coverage ratio
22 Interest service coverage ratio


Cash flow statement — indirect

Amount in (Lakhs)

A Date of start of reporting period 01-04-2025
B Date of end of reporting period 30-09-2025
C Whether results are audited or unaudited
D Nature of report standalone or consolidated Consolidated
1 Statement of cash flows
Cash flows from used in operating activities
Profit before extraordinary items and tax 1,421.31
2 Adjustments for reconcile profit (loss)
Adjustments to profit (loss)
Adjustments for finance costs 346.62
Adjustments for depreciation and amortisation expense 197.88
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 0.00
Adjustments for unrealised foreign exchange losses gains 0.00
Adjustments for dividend income 0.00
Adjustments for share-based payments 0.00
Other adjustments for which cash effects are investing or financing cash flow (50.59)
Other adjustments to reconcile profit (loss) 0.00
Other adjustments for non-cash items 0.00
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0.00
Total adjustments to profit (loss) 493.91
3 Adjustments for working capital
Adjustments for decrease (increase) in inventories (791.08)
Adjustments for decrease (increase) in trade receivables (2,235.91)
Adjustments for decrease (increase) in other current assets (2,001.42)
Adjustments for increase (decrease) in trade payables 1,764.59
Adjustments for increase (decrease) in other current liabilities 1,518.01
Adjustments for provisions 6.25
Total adjustments for working capital (1,739.56)
Total adjustments for reconcile profit (loss) (1,245.65)
Net cash flows from (used in) operations 175.66
Dividends received 0.00
Interest paid 0.00
Interest received 0.00
Income taxes paid (refund) 321.06
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) operating activities before extraordinary items (145.40)
Proceeds from extraordinary items 0.00
Payment for extraordinary items 0.00
Net cash flows from (used in) operating activities (145.40)
4 Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0.00
Cash flows used in obtaining control of subsidiaries or other businesses 0.00
Other cash receipts from sales of equity or debt instruments of other entities 0.00
Other cash payments to acquire equity or debt instruments of other entities 0.00
Other cash receipts from sales of interests in joint ventures 0.00
Other cash payments to acquire interests in joint ventures 0.00
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0.00
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0.00
Proceeds from sales of property plant and equipment 0.00
Purchase of property plant and equipment 1,609.34
Proceeds from sales of intangible assets 0.00
Purchase of intangible assets 0.00
Cash advances and loans made to other parties 0.00
Cash receipts from repayment of advances and loans made to other parties 0.00
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0.00
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0.00
Dividends received 0.00
Interest received 50.59
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash 947.51
Proceeds from government grants 0.00
Net cash flows from (used in) investing activities before extraordinary items (611.24)
Proceeds from extraordinary items 0.00
Payment for extraordinary items 0.00
Net cash flows from (used in) investing activities (611.24)
Cash flows from used in financing activities
Proceeds from issuing shares 0.00
Proceeds from issuing other equity instruments 0.00
Proceeds from issuing debentures notes bonds etc 0.00
Proceeds from borrowings 1,138.13
Repayments of borrowings 21.91
Dividends paid 0.00
Interest paid 346.62
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) financing activities before extraordinary items 769.60
Proceeds from extraordinary items 0.00
Payment for extraordinary items 0.00
Net cash flows from (used in) financing activities 769.60
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes 12.96
6 Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 0.00
Net increase (decrease) in cash and cash equivalents 12.96
Cash and cash equivalents cash flow statement at beginning of period 41.67
Cash and cash equivalents cash flow statement at end of period 54.63


Statement of Asset and Liabilities

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-04-2025
Date of end of reporting period 30-09-2025
Whether results are audited or unaudited Unaudited
Nature of report standalone or consolidated Consolidated
Equity and liabilities
1 Shareholders' funds
Share capital 2,498.96
Reserves and surplus 15,036.62
Money received against share warrants 0.00
Total shareholders' funds 17,535.58
2 Share application money pending allotment 0.00
3 Deferred government grants
4 Minority interest
5 Non-current liabilities
Long-term borrowings 1,566.39
Deferred tax liabilities (net)
Foreign currency monetary item translation difference liability account
Other long-term liabilities
Long-term provisions 99.43
Total non-current liabilities 1,665.82
6 Current liabilities
Short-term borrowings 5,746.87
Trade Payables
(A) Total outstanding dues of micro enterprises and small enterprises 1.92
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 6,617.46
Total Trade payable 6,619.38
Other current liabilities 2,607.41
Short-term provisions 436.44
Total current liabilities 15,410.10
Total equity and liabilities 34,611.50
Assets
1 Non-current assets
i Property, Plant and Equipment and Intangible assets
Property, Plant and Equipment 7,181.48
Producing properties
Intangible assets 142.32
Preproducing properties
Property, Plant and Equipment capital work-in-progress 1,137.84
Intangible assets under development or work-in-progress 143.98
Total Property, Plant and Equipment and Intangible assets 8,605.62
ii Non-current investments 0.09
v Deferred tax assets (net) 27.94
vi Foreign currency monetary item translation difference asset account
vii Long-term loans and advances 469.99
viii Other non-current assets
Total non-current assets 9,103.64
Current assets
Current investments 0.00
Inventories 6,449.41
Trade receivables 12,750.86
Cash and cash equivalents 54.64
Bank balance other than cash and cash equivalents 1,308.59
Short-term loans and advances 4,894.48
Other current assets 49.88
Total current assets 25,507.86
Total assets 34,611.50
Disclosure of notes on assets and liabilities


Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results

Amount in (Lakhs)

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-04-2025 01-04-2025
Date of end of reporting period 30-09-2025 30-09-2025
Whether results are audited or unaudited Unaudited Unaudited
Nature of report standalone or consolidated Consolidated Consolidated
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
1 FERTILIZERS 11,700.32 11,700.32
2 CHEMICALS 38,192.33 38,192.33
3 OTHERS 20.79 20.79
Total Segment Revenue 49,913.44 49,913.44
Less: Inter segment revenue
Revenue from operations 49,913.44 49,913.44
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
1 FERTILIZERS 665.26 665.26
2 CHEMICALS 771.13 771.13
3 OTHERS 0.00 0.00
Total Profit before tax 1,436.39 1,436.39
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income 15.08 15.08
Profit before tax 1,421.31 1,421.31
3 (Segment Asset - Segment Liabilities)
Segment Asset
1 FERTILIZERS 15,004.75 15,004.75
2 CHEMICALS 15,935.39 15,935.39
3 OTHERS 0.00 0.00
4 FERTILIZERS 15,004.75 15,004.75
5 CHEMICALS 15,935.39 15,935.39
6 OTHERS 0.00 0.00
Total Segment Asset 30,940.14 30,940.14
Un-allocable Assets 3,671.36 3,671.36
Net Segment Asset 34,611.50 34,611.50
4 Segment Liabilities
Segment Liabilities
1 FERTILIZERS 15,004.75 15,004.75
2 CHEMICALS 15,935.39 15,935.39
3 OTHERS 0.00 0.00
4 FERTILIZERS 15,004.75 15,004.75
5 CHEMICALS 15,935.39 15,935.39
6 OTHERS 0.00 0.00
Total Segment Liabilities 30,940.14 30,940.14
Un-allocable Liabilities 3,671.36 3,671.36
Net Segment Liabilities 34,611.50 34,611.50
Disclosure of notes on segments